About: Sky Ridge Medical Center

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Sky Ridge Medical Center Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

healthcare organization in Lone Tree, United States

Attributes	Values
rdf:type	Item
owl:sameAs	Sky Ridge Medical Center
description	healthcare organization in Lone Tree, United States (en)
rdfs:label	Sky Ridge Medical Center (en)
skos:prefLabel	Sky Ridge Medical Center (en)
name	Sky Ridge Medical Center (en)
ROR ID	wds:Q30270451-B403BC2E-6D76-4E65-A2CF-95E7C740D9BE
ROR ID	05b820q66
instance of	wds:Q30270451-A5565B51-1586-48F7-8839-7DBE3BB1A6D3
instance of	medical organization
country	wds:Q30270451-D46E3544-B931-44E3-B25F-38DC6C632616
country	United States of America
Google Knowledge Graph ID	wds:Q30270451-32F40031-A785-4BE8-A916-2B5B006C25C6
Ringgold ID	wds:Q30270451-0722A57D-5C59-46D5-AD03-5E1E72D93FC2
Google Knowledge Graph ID	http://g.co/kg/g/1pv6xq1hk
Google Knowledge Graph ID	/g/1pv6xq1hk
Ringgold ID	23684
located in the adm...erritorial entity	wds:Q30270451-546447D1-A4D2-42D0-A2AB-830EC83C05D4
ISNI	wds:Q30270451-9957AEE3-82F1-4645-BC48-9A3E80FBA383
coordinate location	wds:Q30270451-8C0B25F6-AF22-498F-8A9A-90F29729DBDE
official website	wds:Q30270451-68DCCB4A-27E9-4033-A548-41D8170C0D6B
located in the adm...erritorial entity	Lone Tree
ISNI	000000040446032X
coordinate location	POINT(-104.870985 39.529053)
official website	http://skyridgemedcenter.com/
GRID ID	wds:Q30270451-CE95D1D9-F5D1-460F-926F-30DA9783E80A
GRID ID	grid.477920.f
is owl:sameAs of	Sky Ridge Medical Center
is about of	Sky Ridge Medical Center https://www.wikidata.org/wiki/Special:EntityData/Q30270451 Sky Ridge Medical Center
is research site of	Early or Delayed Fludarabine and Rituximab in Treating Patients With Previously Untreated Chronic Lymphocytic Leukemia Zoledronic Acid in Treating Patients With Metastatic Breast Cancer, Metastatic Prostate Cancer, or Multiple Myeloma With Bone Involvement Pembrolizumab in Treating Patients With Locally Advanced Bladder Cancer Platinum Based Chemotherapy or Capecitabine in Treating Patients With Residual Triple-Negative Basal-Like Breast Cancer Following Neoadjuvant Chemotherapy Irinotecan and Cetuximab With or Without Bevacizumab in Treating Patients With Metastatic Colorectal Cancer That Progressed During First-Line Therapy Tamoxifen Citrate or Letrozole With or Without Bevacizumab in Treating Women With Stage IIIB or Stage IV Breast Cancer Chemotherapy With or Without Bevacizumab in Treating Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma The INSPIRE-ASP PNA Trial Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-small Cell Lung Cancer That Was Removed By Surgery Trametinib in Treating Patients With Recurrent or Progressive Low-Grade Ovarian Cancer or Peritoneal Cavity Cancer Rituximab With or Without Stem Cell Transplant in Treating Patients With Minimal Residual Disease-Negative Mantle Cell Lymphoma in First Complete Remission Doxorubicin Hydrochloride, Cyclophosphamide, and Paclitaxel With or Without Bevacizumab in Treating Patients With Lymph Node-Positive or High-Risk, Lymph Node-Negative Breast Cancer Patient-Reported Outcomes in Long-Term Survivors of Colon and Rectal Cancers Methylphenidate in Treating Patients With Fatigue Caused by Cancer Ruxolitinib Phosphate and Dasatinib or Nilotinib in Treating Patients With Chronic Myeloid Leukemia Paclitaxel and Carboplatin or Ifosfamide in Treating Patients With Newly Diagnosed, Persistent or Recurrent Uterine, Ovarian, Fallopian Tube, or Peritoneal Cavity Cancer Pelvic Radiation Therapy or Vaginal Implant Radiation Therapy, Paclitaxel, and Carboplatin in Treating Patients With High-Risk Stage I or Stage II Endometrial Cancer Gabapentin in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy Naloxegol in Treating Patients With Stage IIIB-IV Non-small Cell Lung Cancer Tipifarnib in Treating Patients With Acute Myeloid Leukemia in Remission Interferon Alfa-2b With or Without Bevacizumab in Treating Patients With Advanced Renal Cell Carcinoma (Kidney Cancer) Sorafenib in Treating Patients With Refractory Non-Small Cell Lung Cancer Pentostatin, Cyclophosphamide, and Rituximab Followed By Campath-1H in Patients With Relapsed or Refractory B-Cell CLL Docetaxel With or Without Infliximab in Treating Weight Loss, Loss of Appetite, and Fatigue in Patients With Unresectable Non-Small Cell Lung Cancer (Infliximab Treatment Discontinued Effective 10/05/05) S1406 Phase II Study of Irinotecan and Cetuximab With or Without Vemurafenib in BRAF Mutant Metastatic Colorectal Cancer Paclitaxel With or Without Cixutumumab as Second-Line Therapy in Treating Patients With Metastatic Esophageal Cancer or Gastroesophageal Junction Cancer Everolimus With or Without Bevacizumab in Treating Patients With Advanced Kidney Cancer That Progressed After First-Line Therapy Induction Chemotherapy Followed By Cetuximab and Radiation in HPV-Associated Resectable Stage III/IV Oropharynx Cancer Rosuvastatin in Treating Patients With Stage I or Stage II Colon Cancer That Was Removed By Surgery Ramucirumab and Pembrolizumab Versus Standard of Care in Treating Patients With Stage IV or Recurrent Non-small Cell Lung Cancer (A Lung-MAP Non-Match Treatment Trial) Mupirocin-Iodophor ICU Decolonization Swap Out Trial Nivolumab With or Without Ipilimumab in Treating Patients With Metastatic Sarcoma That Cannot Be Removed by Surgery Collecting Tissue Samples From Patients With Leukemia or Other Blood Disorders Planning to Enroll in an ECOG Leukemia Treatment Clinical Trial Monoclonal Antibody Therapy and Combination Chemotherapy in Treating Patients With Stage II, Stage III, or Stage IV Diffuse Large B-Cell Lymphoma Cetuximab and/or Bevacizumab Combined With Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer Nivolumab and Ipilimumab With or Without Sargramostim in Treating Patients With Stage III-IV Melanoma That Cannot Be Removed by Surgery Ipilimumab or High-Dose Interferon Alfa-2b in Treating Patients With High-Risk Stage III-IV Melanoma That Has Been Removed by Surgery Lenalidomide With or Without Epoetin Alfa in Treating Patients With Myelodysplastic Syndrome and Anemia Pregabalin in Treating Women With Hot Flashes Cixutumumab and Temsirolimus in Treating Patients With Locally Recurrent or Metastatic Breast Cancer Diet and Physical Activity Change or Usual Care in Improving Progression-Free Survival in Patients With Previously Treated Stage II, III, or IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer S1201: Combination Chemo for Patients W/Advanced or Metastatic Esophageal, Gastric, or Gastroesophageal Junction Cancer S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis S0812 High Dose Cholecalciferol in Premenopausal Women at High-Risk for Breast Cancer Dasatinib and Bevacizumab in Treating Patients With Recurrent or Progressive High-Grade Glioma or Glioblastoma Multiforme Creatine in Treating Patients With Cancer-Associated Weight Loss Reduced-Intensity Regimen Before Allogeneic Transplant for Patients With Relapsed Non-Hodgkin's or Hodgkin's Lymphoma Selenium in Preventing Tumor Growth in Patients With Previously Resected Stage I Non-small Cell Lung Cancer Pemetrexed Disodium and Gemcitabine in Treating Patients With Advanced Cancer of the Urothelium Chemotherapy Plus Radiation Therapy in Treating Patients With Stage II or Stage III Anal Cancer Sorafenib and Bevacizumab in Treating Patients With Metastatic Colorectal Cancer Bortezomib and Dexamethasone With or Without Lenalidomide in Treating Patients With Multiple Myeloma Previously Treated With Dexamethasone Nivolumab and Ipilimumab in Treating Patients With Rare Tumors Pemetrexed Disodium and Carboplatin in Treating Patients With Extensive-Stage Small Cell Lung Cancer Docetaxel, Carboplatin, Trastuzumab, and Pertuzumab With or Without Estrogen Deprivation in Treating Patients With Hormone Receptor-Positive, HER2-Positive Operable or Locally Advanced Breast Cancer Paclitaxel With or Without Carboplatin and/or Bevacizumab Followed by Doxorubicin and Cyclophosphamide in Treating Patients With Breast Cancer That Can Be Removed by Surgery Bortezomib, Liposomal Doxorubicin Hydrochloride, Dexamethasone, and Cyclophosphamide in Treating Patients With Multiple Myeloma That Relapsed After Autologous Stem Cell Transplant Radiation Therapy With or Without Temozolomide in Treating Patients With Low-Grade Glioma S1001 PET-Directed Therapy in Treating Patients With Limited-Stage Diffuse Large B-Cell Lymphoma Early Surgery or Standard Palliative Therapy in Treating Patients With Stage IV Breast Cancer Lisinopril or Coreg CR® in Reducing Side Effects in Women With Breast Cancer Receiving Trastuzumab Bevacizumab, Gemcitabine, and Oxaliplatin in Treating Patients With Metastatic Pancreatic Cancer Cetuximab in Treating Patients With Recurrent or Stage IIIB or Stage IV Lung Cancer Bicalutamide With or Without Akt Inhibitor MK2206 in Treating Patients With Previously Treated Prostate Cancer Trametinib and Docetaxel in Treating Patients With Recurrent or Stage IV KRAS Mutation Positive Non-small Cell Lung Cancer Bevacizumab or Pemetrexed Disodium Alone or In Combination After Induction Therapy in Treating Patients With Advanced Non-Squamous Non-Small Cell Lung Cancer Paclitaxel, Carboplatin, and Bevacizumab With or Without Cixutumumab in Treating Patients With Stage IV or Recurrent Non-small Cell Lung Cancer S0809: Capecitabine, Gemcitabine, and RT in Patients w/Cholangiocarcinoma of the Gallbladder or Bile Duct Erlotinib and Gemcitabine With or Without Panitumumab in Treating Patients With Metastatic Pancreatic Cancer

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 195 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software